MDxHealth Financials - Benzinga

MDxHealth SA

MDXHNASDAQ

Trade with Public

Trade with Public

$0.7561

-0.0327-4.15%

At close: Aug 26, 5:00 PM EST

$0.7451

-0.011-1.45%

After Hours: 5:28 PM EST

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare Stock Report

MDxHealth Financials

MDxHealth (MDXH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

MDxHealth Says Well-Positioned to 'Return to Positive EBITDA'

MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue test volumes rise.

Vandana Singh

PRO
MDxHealth Affirms FY2026 Sales Guidance of $110.000M-$115.000M vs $98.814M Est

MDxHealth (NASDAQ:MDXH) affirms FY2026 sales outlook from $110.000 million-$115.000 million to $110.000 million-$115.000 million vs $98.814 million estimate.

Benzinga Newsdesk

PRO
MDxHealth Q2 EPS $(0.18) Misses $(0.16) Estimate, Sales $27.200M Beat $25.884M Estimate

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same

Benzinga Newsdesk

PRO
MDxHealth Lowers FY2026 Sales Guidance from $137.000M-$140.000M to $110.000M-$115.000M vs $135.912M Est

MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.000 million-$115.000 million vs $135.912 million estimate.

Benzinga Newsdesk

PRO
MDxHealth Q1 EPS $(0.17) Misses $(0.12) Estimate, Sales $27.386M Miss $30.620M Estimate

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 10.53 percent increase over losses of $(0.19) per share from the

Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights